register

News & Trends - MedTech & Diagnostics

Prostheses List reforms and sustainability of private healthcare high on medtech sector agenda ahead of Federal Budget

Health Industry Hub | February 8, 2023 |

MedTech News: The Medical Technology Association of Australia (MTAA) has raised several issues impacting the medtech sector and the broader care for patients in its pre-Budget submission.

Ian Burgess, CEO of MTAA joined Health industry Hub to discuss concerns relating to the current cost recovery funding model for the TGA, the anticipated impact on the medtech sector and the availability of innovative technologies for Australian patients.

Mr Burgess reflected on the Prostheses List (PL) reforms which have been complex and challenging, involving a diverse range of stakeholders. Fifty-one per cent (51%) of medical devices on the PL had a benefit reduction on 1 July 2022, with further reductions to follow on 1 March and 1 July 2023. Savings of over $80m will be delivered in 2022-23. The MTAA pre-budget submission points to several issues relating to the PL reforms.

As we face significant challenges across the broader healthcare ecosystem impacting patient care, Mr Burgess acknowledged the evolution in the digital health sector since 2020 and the potential impact of enhancing care. However, local regulation and reimbursement frameworks remain a key barrier to broader reimbursement of digital health applications for use in the community and uptake by clinicians and consumers. Mr Burgess discussed the impact on the medtech sector and MTAA’s recommendations to government on this matter.

A reform agenda “with a whole government approach” is critical to drive a sustainable health sector. Mr Burgess said the MTAA is urging the government to implement several measures, including a Private Health System Authority, to oversee private health insurance “to increase sustainability, improve the value proposition and to protect patients.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Manoj Saxena - Bayer

Breaking the mold: Bayer GM on the future of pharma workplaces – Reimagining Healthcare Senior Leadership Series

Health Industry Hub | July 18, 2024 |

In the latest episode of the Reimagining Healthcare senior leadership series, Manoj Saxena, General Manager Pharmaceuticals ANZ at Bayer voiced […]

More


News & Trends - Pharmaceuticals

Matt Zeller, Country President of Novartis ANZ

Novartis Country President talks essentials in shaping the future of health policy: Reimagining Healthcare senior leadership series

Health Industry Hub | July 18, 2024 |

In this episode of the Reimagining Healthcare senior leadership series, Matt Zeller, Country President of Novartis ANZ, explores how health […]

More


Medical

First guidelines to stamp out rising scientific integrity issues in medical journals

First guidelines to stamp out rising scientific integrity issues in medical journals

Health Industry Hub | July 18, 2024 |

The number of retractions issued for scientific research articles in 2023 exceeded 10,000 – smashing annual records. To date, publishers […]

More


News & Trends - Pharmaceuticals

Gilead secures MSAC nod for CAR-T therapy

Gilead secures MSAC nod for CAR-T therapy

Health Industry Hub | July 18, 2024 |

Pharma News: Gilead Sciences welcomes the Medical Services Advisory Committee (MSAC) recommendation for public funding of Yescarta (axicabtagene ciloleucel) as […]

More


This content is copyright protected. Please subscribe to gain access.